Rosiglitazone reverses insulin secretion altered by chronic exposure to free fatty acid via IRS-2-associated phosphatidylinositol 3-kinase pathway.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples